SAMN26860800
External Id
dbGaP
INSDC center name
2022-03-22T02:46:50.153Z
INSDC first public
2022-12-16T02:48:16.750Z
INSDC last update
SRS12717294
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS12717294
SRA accession
cfDNA
analyte type
Palbociclib_Bazedoxifene_BC
biospecimen repository
RJP2C1D23_P
biospecimen repository sample id
BLOOD
body site
phs002802
gap_accession
1
gap_consent_code
HMB
gap_consent_short_name
4899574
gap_sample_id
3887623
gap_subject_id
Adenocarcinoma
http://www.ebi.ac.uk/efo/EFO_0000571
histological type
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
female
http://purl.obolibrary.org/obo/PATO_0000383
sex
Clinical Trial
study design
Phase IB/II Study of Bazedoxifene in Combination with Palbociclib in Patients with Endocrine Resistant Hormone Receptor-Positive Breast Cancer
study name
RJP2C1D23_P
submitted sample id
RJ23
submitted subject id
Palbociclib_Bazedoxifene_BC
submitter handle
cfDNA sample from BLOOD of a human female participant in the dbGaP study Phase IB/II Study of Bazedoxifene in Combination with Palbociclib in Patients with Endocrine Resistant Hormone Receptor-Positive Breast Cancer
title